Literature DB >> 3745032

The carrier state: Clostridium difficile.

R H George.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3745032     DOI： 10.1093/jac/18.supplement_a.47

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  8 in total

1.  Impaired detection of faecal verocytotoxin in the presence of Clostridium difficile cytotoxin in patients with haemolytic uraemic syndrome.

Authors:  I Luzzi; F Minelli; A Gianviti; A Caprioli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-10       Impact factor: 3.267

2.  Clostridium difficile: a pathogen of the nineties.

Authors:  T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-03       Impact factor: 3.267

3.  Electrophoretic characterization of Clostridium difficile strains isolated from antibiotic-associated colitis and other conditions.

Authors:  A Pantosti; M Cerquetti; P M Gianfrilli
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

4.  The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?

Authors:  Justyna Bien; Vindhya Palagani; Przemyslaw Bozko
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

5.  Heterogeneity of Clostridium difficile isolates from infants.

Authors:  A Collignon; L Ticchi; C Depitre; J Gaudelus; M Delmée; G Corthier
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

6.  Prolonged carriage of Clostridium difficile in Hirschsprung's disease.

Authors:  S P Hardy; R Bayston; L Spitz
Journal:  Arch Dis Child       Date:  1993-08       Impact factor: 3.791

7.  An epidemic of pseudomembranous colitis: importance of person to person spread.

Authors:  N P Nolan; C P Kelly; J F Humphreys; C Cooney; R O'Connor; T N Walsh; D G Weir; D S O'Briain
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

8.  Treatment of Clostridium difficile-associated disease with teicoplanin.

Authors:  F de Lalla; G Privitera; E Rinaldi; G Ortisi; D Santoro; G Rizzardini
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.